SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-22-002605
Filing Date
2022-08-15
Accepted
2022-08-15 17:13:01
Documents
40
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q atxi-20220630x10q.htm   iXBRL 10-Q 727146
2 EX-10.1 atxi-20220630xex10d1.htm EX-10.1 265632
3 EX-31.1 atxi-20220630xex31d1.htm EX-31.1 11660
4 EX-31.2 atxi-20220630xex31d2.htm EX-31.2 11810
5 EX-32.1 atxi-20220630xex32d1.htm EX-32.1 5291
6 EX-32.2 atxi-20220630xex32d2.htm EX-32.2 5840
  Complete submission text file 0001410578-22-002605.txt   2710796

Data Files

Seq Description Document Type Size
7 EX-101.SCH atxi-20220630.xsd EX-101.SCH 19110
8 EX-101.CAL atxi-20220630_cal.xml EX-101.CAL 16493
9 EX-101.DEF atxi-20220630_def.xml EX-101.DEF 94294
10 EX-101.LAB atxi-20220630_lab.xml EX-101.LAB 145211
11 EX-101.PRE atxi-20220630_pre.xml EX-101.PRE 129180
34 EXTRACTED XBRL INSTANCE DOCUMENT atxi-20220630x10q_htm.xml XML 233416
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 781-652-4500
AVENUE THERAPEUTICS, INC. (Filer) CIK: 0001644963 (see all company filings)

IRS No.: 474113275 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38114 | Film No.: 221166678
SIC: 2834 Pharmaceutical Preparations